Ra Capital Management, L.p. bought $6.9M of PBLS
director, owner at Parabilis Medicines, Inc.. 244,593 shares at an average of $28.29, traded Jul 20, 2026, filed Jul 22, 2026.
Score components
- +15RoleDirector
- +25Trade size$6.9M at market
- -5Relative to holdingsUnder 1% of holdings (0.9%)
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- +5Repeat buying2 buys in 90 days
- -5Track recordMedian 6-month excess return -16% over 21 past buys
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001231919-26-000779, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 20, 2026 | POpen-market purchase Voting Common Stockindirect: See footnotes | +98,433 | $27.13 | $2.7M | 26,383,526 | Jul 22, 2026 |
| Jul 20, 2026 | POpen-market purchase Voting Common Stockindirect: See footnotes | +32,987 | $27.72 | $914k | 26,416,513 | Jul 22, 2026 |
| Jul 21, 2026 | POpen-market purchase Voting Common Stockindirect: See footnotes | +21,696 | $27.96 | $607k | 26,438,209 | Jul 22, 2026 |
| Jul 21, 2026 | POpen-market purchase Voting Common Stockindirect: See footnotes | +6,504 | $29.17 | $190k | 26,444,713 | Jul 22, 2026 |
| Jul 21, 2026 | POpen-market purchase Voting Common Stockindirect: See footnotes | +37,723 | $30.00 | $1.1M | 26,482,436 | Jul 22, 2026 |
| Jul 22, 2026 | POpen-market purchase Voting Common Stockindirect: See footnotes | +47,250 | $29.77 | $1.4M | 26,529,686 | Jul 22, 2026 |
Related signals
Other insiders at Parabilis Medicines, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 57Moderate | Parabilis Medicines, Inc. | Guy Levy owner | $10M 500,000 shares | +77% | |
| 62Notable | Parabilis Medicines, Inc. | Alan Sebulsky director | $474k 17,500 shares | +140% | |
| 60Notable | Parabilis Medicines, Inc. | Ra Capital Management, L.p. director, owner | $424M 21,188,750 shares | +323% | |
| 51Moderate | Parabilis Medicines, Inc. | Alan Sebulsky director | $250k 12,500 shares | - |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.